Hepatitis Monthly. 2004; 4 (8): 165-169
em Inglês
| IMEMR
| ID: emr-203607
ABSTRACT
Aim:
in patients with chronic hepatitis B and compensated liver disease, lamivudine reduces s e m HBV-DNA to undetectable levels within 1 to 2 months of treatment. The aim of this study was to evaluate the efficacy of lamivudine in cases with hepatitis B related cirrhosis
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Hepat. Monthly
Ano de publicação:
2004
Similares
MEDLINE
...
LILACS
LIS